GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $286K invested in Galmed Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$65.9K
2
+$9.04K

Top Sellers

1
-$61.1K
2
-$18K
3
-$13.3K
4
Millennium Management
Millennium Management
New York
-$12.5K
5
Two Sigma Investments
Two Sigma Investments
New York
-$3.28K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$123K
2
$75K
3
$52.5K
4
$20.2K
5
$10.7K
6
$5.12K
7
$93
8
$76
9
$24
10
$16
11
$8
12
$5
13
–
14
–
15
–
16
–